medullary thyroid carcinoma
Conditions
Interventions
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent form. 2. Age = one year old. 3. MTC patients highly suspected or confirmed by pathological or routine imaging examinations, with CT levels>150 pg/mL and CEA greater than the upper limit of the reference value. According to the doctor's judgment, the expected survival period is 3 months. 5. Agree to implement strict contraception for at least 28 days after PET/CT examination. 6. Willing and able to follow the research plan.
Exclusion criteria
Exclusion criteria: If any of the following conditions exist in the subjects, they will be excluded from this study: Patients diagnosed with other malignant tumors in the past year. 2. Thyroid cancer patients diagnosed with other pathological types during follow-up. 3. Patients undergoing any anti-tumor treatment between two PET/CT scans. 4. Pregnant or lactating women. 5. Cannot lie down on the PET/CT scanning bed or tolerate PET examination during the scanning period. 6. Patients who have received or are currently receiving treatments such as radiotherapy, chemotherapy, immunotherapy, or molecular targeted therapy. 7. Have participated in other interventional clinical trials within the previous month before screening. 8. Patients who have been lost to follow-up. According to the researcher's assessment, the subjects have other circumstances that may affect the study or make them unsuitable to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax (Standardized Uptake Value max); | — |
Countries
China
Contacts
Public ContactShaoli Song
Fudan University Shanghai Cancer Center
Outcome results
None listed